One can only surmise that there must be a plan of inaction for a certain period of time till there is a benefit, that is if there are really accumulating profits. Is anyone aquiring stock from old anxious holders of the previous company? Seems with this new treatment there is a window of opportunity that is being missed if it really is effective. Won't other stem cell companies quickly adapt to the process. the longer it takes to get this "brand name" established? Would rather see building news then a flurry after a set period of time in the interest of long term prospects.